Cargando…

Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: Meta-analysis and trial sequential analysis of randomized controlled trials

We aimed to compare resection and survival outcomes of neoadjuvant chemoradiotherapy (CRT) and immediate surgery in patients with resectable pancreatic cancer (RPC) or borderline resectable pancreatic cancer (BRPC). In compliance with the Preferred Reporting Items for Systematic Reviews and Meta-Ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hajibandeh, Shahab, Hajibandeh, Shahin, Intrator, Christina, Hassan, Karim, Sehmbhi, Mantej, Shah, Jigar, Mazumdar, Eshan, Kausar, Ambareen, Satyadas, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association of Hepato-Biliary-Pancreatic Surgery 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9947376/ https://www.ncbi.nlm.nih.gov/pubmed/36536501 http://dx.doi.org/10.14701/ahbps.22-052

Ejemplares similares

Procedural outcomes of laparoscopic caudate lobe resection: A systematic review and meta-analysis
por: Hajibandeh, Shahab, et al.
Publicado: (2023)

Accuracy of the END-PAC Model in Predicting the Risk of Developing Pancreatic Cancer in Patients with New-Onset Diabetes: A Systematic Review and Meta-Analysis
por: Hajibandeh, Shahab, et al.
Publicado: (2023)

Meta-analysis and trial sequential analysis of randomized evidence comparing general anesthesia vs regional anesthesia for laparoscopic cholecystectomy
por: Asaad, Peter, et al.
Publicado: (2021)

Preoperative C-Reactive Protein-to-Albumin Ratio and Its Ability to Predict Outcomes of Pancreatic Cancer Resection: A Systematic Review
por: Hajibandeh, Shahin, et al.
Publicado: (2023)

Who should lead a trauma team: Surgeon or non-surgeon? A systematic review and meta-analysis
por: Hajibandeh, Shahab, et al.
Publicado: (2017)

A Specific Criteria-Based Guideline Improves Compliance With General Surgery Ambulatory Care Standards and Reduces Overcrowding in “Hot Clinic”: A Quality Improvement Study
por: Anwer, Amal A, et al.
Publicado: (2022)

Systematic review: effect of whole-body computed tomography on mortality in trauma patients
por: Hajibandeh, Shahab, et al.
Publicado: (2015)

Systematic Review: Adjuvant Chemotherapy for Locally Advanced Rectal Cancer with respect to Stage of Disease
por: Hajibandeh, Shahab, et al.
Publicado: (2015)

The Time Is Now to Use Clinical Outcomes as Quality Indicators for Effective Leadership in Trauma
por: Hajibandeh, Shahab, et al.
Publicado: (2017)

Effect of ghrelin administration on postoperative inflammatory response and bodyweight loss in patients with oesophageal cancer undergoing oesophagectomy: a systematic review and meta-analysis
por: Forshaw, Elizabeth, et al.
Publicado: (2023)

Transperitoneal repair of a juxtarenal abdominal aortic aneurysm and co-existent horseshoe kidney with division of the renal isthmus
por: Hajibandeh, Shahin, et al.
Publicado: (2015)

Meta-analysis of transanal vs laparoscopic total mesorectal excision of low rectal cancer: Importance of appropriate patient selection
por: Bhattacharya, Pratik, et al.
Publicado: (2022)

Robot-assisted laparoscopic pyeloplasty versus laparoscopic pyeloplasty for pelvi-ureteric junction obstruction in the paediatric population: a systematic review and meta-analysis
por: Taktak, Samih, et al.
Publicado: (2019)

The Nellix endovascular aneurysm sealing system: current perspectives
por: Choo, Xin Y, et al.
Publicado: (2019)

Meta-analysis of epidural analgesia versus peripheral nerve blockade after total knee joint replacement
por: Toner, Ethan, et al.
Publicado: (2017)

Neoadjuvant Treatment for Resectable and Borderline Resectable Pancreatic Cancer: Chemotherapy or Chemoradiotherapy?
por: Versteijne, Eva, et al.
Publicado: (2022)

Multicenter randomized controlled trial of neoadjuvant chemoradiotherapy alone or in combination with pembrolizumab in patients with resectable or borderline resectable pancreatic adenocarcinoma
por: Katz, Matthew H G, et al.
Publicado: (2023)

Predictive Performance of NELA Versus P-POSSUM Mortality Scores: Are We Underestimating the Risk of Mortality Following Emergency Laparotomy?
por: Barghash, Mohammed, et al.
Publicado: (2022)

Meta‐analysis of the demographic and prognostic significance of gastrointestinal symptoms in COVID‐19 patients
por: Zaman, Shafquat, et al.
Publicado: (2022)

Preoperative radiochemotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer (PREOPANC trial): study protocol for a multicentre randomized controlled trial
por: Versteijne, Eva, et al.
Publicado: (2016)

Definitive chemoradiotherapy for squamous cell carcinoma of the esophagus: outcomes for borderline-resectable disease
por: Ishikura, Satoshi, et al.
Publicado: (2020)

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials
por: Cloyd, Jordan M., et al.
Publicado: (2020)

Use of combined laboratory and ultrasonography results to select patients for biliary tract imaging or intervention: a retrospective cohort study
por: Hajibandeh, Shahab, et al.
Publicado: (2019)

Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer
por: Oshima, Minoru, et al.
Publicado: (2020)

Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable T3-4N0–1 non-small cell lung cancer: the INCREASE trial
por: Dickhoff, Chris, et al.
Publicado: (2020)

Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials
por: Doppenberg, Deesje, et al.
Publicado: (2023)

Prognostic value of neoadjuvant therapy for resectable and borderline resectable pancreatic cancer: A meta-analysis of randomized controlled trials
por: Liu, Shangtong, et al.
Publicado: (2023)

Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial
por: Janssen, Q. P., et al.
Publicado: (2021)

Significance of neoadjuvant chemoradiotherapy for borderline resectable pancreatic head cancer: Pathological local invasion and microvessel invasion analysis
por: Naito, Yoshiki, et al.
Publicado: (2019)

Should a colonoscopy be offered routinely to patients with CT proven acute diverticulitis? A retrospective cohort study and meta-analysis of best available evidence
por: Asaad, Peter, et al.
Publicado: (2019)

Neoadjuvant Treatment in Patients With Resectable and Borderline Resectable Pancreatic Cancer
por: Janssen, Quisette P., et al.
Publicado: (2020)

Editorial: Neoadjuvant treatment for resectable and borderline resectable pancreatic cancer
por: Massani, Marco, et al.
Publicado: (2023)

Perioperative Predictors of Early Recurrence for Resectable and Borderline-Resectable Pancreatic Cancer
por: Imamura, Masafumi, et al.
Publicado: (2021)

Borderline resectable pancreatic cancer and vascular resections in the era of neoadjuvant therapy
por: Mikulic, Danko, et al.
Publicado: (2021)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
por: Anvari, Kazem, et al.
Publicado: (2015)

Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer
por: Fiore, Michele, et al.
Publicado: (2017)

Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II–III resectable rectal cancer: a meta-analysis of randomized controlled trials
por: Song, Jin Ho, et al.
Publicado: (2017)

Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment
por: Crowley, Fionnuala, et al.
Publicado: (2023)

Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons
por: Nichols, Romaine Charles, et al.
Publicado: (2019)

Borderline resectable pancreatic cancer: Certainties and controversies
por: Nappo, Gennaro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g9o4itih4oaq6juaunka65ta9e